Valion Bio VBIO Director · filings 2026 to 2026
No transactions in the filings read; Form 144 notices are listed above.
Person · CIK 1888277
Thomas Jensen
Director at Valion Bio; CEO at Allarity Therapeutics
Sold on Form 4$0
Noticed on Form 144$0
Bought on Form 4$0
Companies2
Holdings now
As reported after the latest Form 3, 4 or 5 at each company.
How these figures work
Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.
| Company | Security | Held | Shares or units | As of |
|---|---|---|---|---|
| Allarity Therapeutics ALLR | Common Stock | Directly | 596,734 | Jan 28, 2026 · Filing · EDGAR |
| Allarity Therapeutics ALLR | Common Stock, $0.0001 | Directly | 17,841 | Dec 20, 2021 · Filing · EDGAR |
| Allarity Therapeutics ALLR | Stock Options exercise $5.16, expires Nov 23, 2026, into Common Stock | Directly | 161,516 | Dec 20, 2021 · Filing · EDGAR |
Sold and noticed by quarter
No sales or Form 144 notices with a stated value.
Every transaction, by company
Each Form 3, 4 and 5 transaction in plain words, newest first.
How these figures work
Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.
Allarity Therapeutics ALLR CEO · filings 2021 to 2026
All 4 Forms 3, 4, 5 and 144
| Filed | Form | Company | Links |
|---|---|---|---|
| Sep 17, 2026 | Form 3 | Valion Bio VBIO | Filing · EDGAR |
| May 14, 2026 | Form 4 | Allarity Therapeutics ALLR | Filing · EDGAR |
| Jan 24, 2025 | Form 4 | Allarity Therapeutics ALLR | Filing · EDGAR |
| Dec 22, 2021 | Form 3 | Allarity Therapeutics ALLR | Filing · EDGAR |
Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.